Literature DB >> 16439416

When to test women for human papillomavirus: testing is possible without increasing colposcopy referral rate.

Johannes Berkhof, Folkert J van Kemenade, Peter J Snijders, René H Verheijen, Chris J Meijer.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16439416      PMCID： PMC1352067          DOI： 10.1136/bmj.332.7535.237

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

Authors:  Nicole W J Bulkmans; Lawrence Rozendaal; Peter J F Snijders; Feja J Voorhorst; A Joan P Boeke; Gladys R J Zandwijken; Folkert J van Kemenade; René H M Verheijen; Krijn v Groningen; Mathilde E Boon; Hans J F Keuning; Marjolein van Ballegooijen; Adriaan J C van den Brule; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

2.  Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study.

Authors:  Sue Moss; Alastair Gray; Rosa Legood; Martin Vessey; Julietta Patnick; Henry Kitchener
Journal:  BMJ       Date:  2006-01-06

3.  Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.

Authors:  Johannes Berkhof; Martine C de Bruijne; Gilda D Zielinski; Nicole W J Bulkmans; Lawrence Rozendaal; Peter J F Snijders; René H M Verheijen; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.